Up-regulated expression of decay-accelerating factor (CD55) confers increased complement resistance to sprouting neural cells

European Journal of Immunology

Volumn 28, Issue 4, 1998, Pages 1189-1196

  Zhang, Ke Zhou ^a   Junnikkala, Sami ^a   Erlander, Mark G ^b   Guo, Hongqing ^b   Westberg, Johan A ^a   Meri, Seppo ^a   Andersson, Leif C ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b R W Johnson Pharmaceutical Res I   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cellular differentiation; Complement; Neuroimmunology

Indexed keywords

COMPLEMENT; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADOLESCENT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DENDRITE; FEMALE; HUMAN; NERVE CELL DIFFERENTIATION; NERVE FIBER; NERVE REGENERATION; NERVE SPROUTING; NEURAL CREST; NEUROIMMUNOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD55; CARCINOGENS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; NEURAL CREST; NEURONS; TETRADECANOYLPHORBOL ACETATE; UP-REGULATION;

EID: 0031960063     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199804)28:04<1189::AID-IMMU1189>3.0.CO;2-D     Document Type: Article

References (25)

1. Zhang, K. Z., Westberg, J. A., Höltta, E. and Andersson, L. C., BCL2 regulates neural differentiation. Proc. Natl. Acad. Sci. USA 1996. 93: 4504-4508.
2. Nicholson-Weller, A., Burge, J., Fearon, D. T., Weller, P. F. and Austen, K. F., Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 1982. 129: 184-189.
3. Seya, T., Turner, J. R. and Atkinson, J. P., Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 1986. 163: 837-855.
4. Davies, A., Simmons, D. L., Hale, G., Harrison, R. A., Tighe, H., Lachmann, P. J. and Waldmann, H., CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 1989. 170: 637-654.
5. Meri, S., Morgan, B. P., Davies, A., Daniels, R. H., Olavesen, M. G., Waldmann, H. and Lachmann, P. J., Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-7 catalysed insertion of C9 into lipid bilayers. Immunology 1990. 71: 1-9.
6. Rollins, S. A., Zhao, J., Ninomiya, H. and Sims, P. J., Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J. Immunol. 1991. 146: 2345-2351.
7. Morgan, B. P. and Meri, S., Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 1994. 15: 369-396.
8. Vedeler, C., Ulvestad, E., Bjørge, L., Conti, G., Williams, K., Mork, S. and Matre, R., The expression of CD59 in normal human nervous tissue. Immunology 1994. 82: 542-547.
9. Akatsu, H., Yamada, T., Okada, N., Yamamoto, T., Yamashina, M. and Okada, H., Unique expression of HRF20 (CD59) in human nervous tissue. Microbiol. Immunol. 1997. 41: 321-329.
10. McGeer, P. L., Walker, D. G., Akiyama, H., Kawamata, T., Guan, A. L., Parker, C. J., Okada, N. and McGeer, E. G., Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain Res. 1991. 544: 315-319.
11. Lindsberg, P. J., Öhman, J., Lehto, T., Karjalainen-Lindsberg, M. L., Paetau, A., Wuorimaa, T., Carpen, O., Kaste, M. and Meri, S., Complement activation in the central nervous system following blood-brain barrier damage in man. Ann. Neurol. 1996. 40: 587-596.
12. Hartung, H. P. and Rieckmann, P., Pathogenesis of immune-mediated demyelination in the CNS. J. Neural. Transm. Suppl. 1997. 50: 173-181.
13. Hafer-Macko, C., Hsieh, S. T., Li, C. Y., Ho, T. W., Sheikh, K., Cornblath, D. R., McKhann, G. M., Asbury, A. K. and Griffin, J. W., Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 1996. 40: 635-644.
14. Mäenpää, A., Junnikkala, S., Hakulinen, J., Timonen, T. and Meri, S., Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas. Am. J. Pathol. 1996. 148: 1139-1152.
15. Bjørge, L., Hakulinen, J., Wahlström, T., Matre, R. and Meri, S., Complement-regulatory proteins in ovarian malignancies. Int. J. Cancer 1997. 70: 14-25.
16. Gasque, P., Thomas, A., Fontaine, M. and Morgan, B. P., Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. J. Neuroimmunol. 1996. 66: 29-40.
17. Rettig, W. J., Spengler, B. A., Chesa, P. G., Old, L. J. and Biedler, J. L., Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res. 1987. 47: 1383-1389.
18. Berger, M. and Medof, M. E., Increased expression of complement decay-accelerating factor during activation of human neutrophils. J. Clin. Invest. 1987. 79: 214-220.
19. Bernet-Camard, M. F., Coconier, M. H., Hudault, S. and Servin, A. L., Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines. Gut 1996. 38: 248-253.
20. Kendall, G., Crankson, H., Ensor, E., Lublin, D. M. and Latchman, D. S., Activation of the gene encoding decay accelerating factor following nerve growth factor treatment of sensory neurons is mediated by promoter sequences within 206 bases of the transcriptional start site. J. Neurosci. Res. 1996. 45: 96-103.
21. Ewulonu, U. K., Ravi, L. and Medof, M. E., Characterization of the decay-accelerating factor gene promoter region. Proc. Natl. Acad. Sci. USA 1991. 88: 4675-4679.
22. Hamann, J., Vogel, B., van Schijndel, G. M. and van Lier, R. A., The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med. 1996. 184: 1185-1189.
23. Aust, G., Eichler, W. and Laue, S., CD97: a dedifferentiation marker in human thyroid carcinomas. Cancer Res. 1997. 57: 1798-1806.
24. Liang, P. and Pardee, A. B., Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992. 257: 967-971.
25. Wan, J., Sharp, S., Poirier, G., Wagaman, P., Chambers, J., Pyati, J., Hom, Y.-L., Galindo, J., Huvar, A., Peterson, P., Jackson, M. and Erlander, M., Cloning Differentially Expressed mRNAs. Nature Biotechnol. 1996. 14: 685-1691.